Ghrelin suppresses inflammation in HUVECs by inhibiting ubiquitin-mediated uncoupling protein 2 degradation

Zhang,Ruolan

doi:10.3892/ijmm.2017.2977

Ghrelin suppresses inflammation in HUVECs by inhibiting ubiquitin-mediated uncoupling protein 2 degradation

Authors:
- Ruolan Zhang
View Affiliations

Affiliations: Department of Cardiology, Harrison International Peace Hospital, Hengshui, Hebei 053000, P.R. China
Published online on: May 5, 2017 https://doi.org/10.3892/ijmm.2017.2977
Pages: 1421-1427
Copyright: © Zhang . This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Atherosclerosis is considered the major cause of heart attack, stroke and gangrene of the extremities, which is responsible for 50% of all mortality in Western countries. The pathogenesis and causes of atherosclerosis remain elusive. Recent studies highlight inflammation as a contributing factor for atherosclerosis in all stages of the disease process. In this study, we demonstrate that the treatment of human umbilical vein endothelial cells (HUVECs) with ghrelin inhibits the oxidized low-density lipoprotein (oxLDL)-induced inflammatory response, In addition, treatment with ghrelin led to the accumulation of uncoupling protein 2 (UCP2) in the cells, thus decreasing reactive oxygen species (ROS) generation. Moreover, the siRNA-mediated knockdown of UCP2 expression suggested that the inhibitory effects of ghrelin on the inflammatory response relied on its ability to induce the accumulation of cellular UCP2 levels. Further analysis indicated that the accumulation of UCP2 in the ghrelin-treated cells was due to the ability of ghrelin to inhibit the ubiquitination of UCP2 and prevent UCP2 degradation, resulting in the extended protein half-life of UCP2. On the whole, our data indicate that ghrelin inhibits the oxLDL-induced inflammatory response in HUVECs, and may thus have potential for use as an anti-atherosclerotic agent. Our data may also provide valuable insight into the pathogenesis of atherosclerosis.

View Figures

View References

1	Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
2	Perez-Ruiz F and Becker MA: Inflammation: A possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease. Curr Med Res Opin. 31(Suppl 2): 9–14. 2015. View Article : Google Scholar : PubMed/NCBI
3	Packard RR and Libby P: Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction. Clin Chem. 54:24–38. 2008. View Article : Google Scholar
4	Funk SD, Yurdagul A Jr and Orr AW: Hyperglycemia and endothelial dysfunction in atherosclerosis: Lessons from type 1 diabetes. Int J Vasc Med. 2012:5696542012.PubMed/NCBI
5	Schanberg LE and Sandborg C: Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythe-matosus. Curr Rheumatol Rep. 6:425–433. 2004. View Article : Google Scholar : PubMed/NCBI
6	Miller YI, Chang MK, Binder CJ, Shaw PX and Witztum JL: Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol. 14:437–445. 2003. View Article : Google Scholar : PubMed/NCBI
7	Cybulsky MI and Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 251:788–791. 1991. View Article : Google Scholar : PubMed/NCBI
8	Li H, Cybulsky MI, Gimbrone MA Jr and Libby P: An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 13:197–204. 1993. View Article : Google Scholar : PubMed/NCBI
9	Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW and Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 107:1255–1262. 2001. View Article : Google Scholar : PubMed/NCBI
10	Farmer JA and Torre-Amione G: Atherosclerosis and inflammation. Curr Atheroscler Re. 4:92–98. 2002. View Article : Google Scholar
11	Dickson SL, Egecioglu E, Landgren S, Skibicka KP, Engel JA and Jerlhag E: The role of the central ghrelin system in reward from food and chemical drugs. Mol Cell Endocrinol. 340:80–87. 2011. View Article : Google Scholar : PubMed/NCBI
12	Baatar D, Patel K and Taub DD: The effects of ghrelin on inflammation and the immune system. Mol Cell Endocrinol. 340:44–58. 2011. View Article : Google Scholar : PubMed/NCBI
13	Kadoglou NP, Sailer N, Moumtzouoglou A, Kapelouzou A, Tsanikidis H, Vitta I, Karkos C, Karayannacos PE, Gerasimidis T and Liapis CD: Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 118:75–80. 2010. View Article : Google Scholar
14	Li Y, Hai J, Li L, Chen X, Peng H, Cao M and Zhang Q: Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine. 43:376–386. 2013. View Article : Google Scholar
15	Patel D, Opriessnig T, Stein DA, Halbur PG, Meng XJ, Iversen PL and Zhang YJ: Peptide-conjugated morpholino oligomers inhibit porcine reproductive and respiratory syndrome virus replication. Antiviral Res. 77:95–107. 2008. View Article : Google Scholar
16	Patel D, Nan Y, Shen M, Ritthipichai K, Zhu X and Zhang YJ: Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol. 84:11045–11055. 2010. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
18	Peshavariya HM, Dusting GJ and Selemidis S: Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase. Free Radic Res. 41:699–712. 2007. View Article : Google Scholar : PubMed/NCBI
19	Nan Y, Wang R, Shen M, Faaberg KS, Samal SK and Zhang YJ: Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology. 432:261–270. 2012. View Article : Google Scholar : PubMed/NCBI
20	Nan Y, Ma Z, Wang R, Yu Y, Kannan H, Fredericksen B and Zhang YJ: Enhancement of interferon induction by ORF3 product of hepatitis E virus. J Virol. 88:8696–8705. 2014. View Article : Google Scholar : PubMed/NCBI
21	Liu W, Yin Y, Zhou Z, He M and Dai Y: OxLDL-induced IL-1 beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflam-masome activation. Inflamm Res. 63:33–43. 2014. View Article : Google Scholar
22	Magwenzi S, Woodward C, Wraith KS, Aburima A, Raslan Z, Jones H, McNeil C, Wheatcroft S, Yuldasheva N, Febbriao M, et al: Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade. Blood. 125:2693–2703. 2015. View Article : Google Scholar : PubMed/NCBI
23	Salganik RI: The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr. 20(Suppl 5): 464S–475S. 2001. View Article : Google Scholar : PubMed/NCBI
24	Lobo V, Patil A, Phatak A and Chandra N: Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 4:118–126. 2010. View Article : Google Scholar : PubMed/NCBI
25	Echtay KS: Mitochondrial uncoupling proteins - what is their physiological role? Free Radic Biol Med. 43:1351–1371. 2007. View Article : Google Scholar : PubMed/NCBI
26	Donadelli M, Dando I, Fiorini C and Palmieri M: UCP2, a mitochondrial protein regulated at multiple levels. Cell Mol Life Sci. 71:1171–1190. 2014. View Article : Google Scholar
27	Krauss S, Zhang CY and Lowell BB: The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol. 6:248–261. 2005. View Article : Google Scholar : PubMed/NCBI
28	Lin CS and Klingenberg M: Characteristics of the isolated purine nucleotide binding protein from brown fat mitochondria. Biochemistry. 21:2950–2956. 1982. View Article : Google Scholar : PubMed/NCBI
29	Xu L and Qu Z: Roles of protein ubiquitination and degradation kinetics in biological oscillations. PLoS One. 7:e346162012. View Article : Google Scholar : PubMed/NCBI
30	Azzu V and Brand MD: Degradation of an intramitochondrial protein by the cytosolic proteasome. J Cell Sci. 123:578–585. 2010. View Article : Google Scholar : PubMed/NCBI
31	Fleury C, Neverova M, Collins S, Raimbault S, Champigny O, Levi-Meyrueis C, Bouillaud F, Seldin MF, Surwit RS, Ricquier D and Warden CH: Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat Genet. 15:269–272. 1997. View Article : Google Scholar : PubMed/NCBI
32	Boss O, Samec S, Paoloni-Giacobino A, Rossier C, Dulloo A, Seydoux J, Muzzin P and Giacobino JP: Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 408:39–42. 1997. View Article : Google Scholar : PubMed/NCBI
33	Azzu V and Brand MD: The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem Sci. 35:298–307. 2010. View Article : Google Scholar
34	Richard D and Picard F: Brown fat biology and thermogenesis. Front Biosci (Landmark Ed). 16:1233–1260. 2011. View Article : Google Scholar
35	Garlid KD, Jabůrek M, Jezek P and Varecha M: How do uncoupling proteins uncouple? Biochim Biophys Acta. 1459:383–389. 2000. View Article : Google Scholar : PubMed/NCBI
36	Mattiasson G and Sullivan PG: The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal. 8:1–38. 2006. View Article : Google Scholar : PubMed/NCBI